BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,406.70
0.57%
S&P ASX All Technology
3,915.30
0.60%
Brent Oil
72.425
-0.03%
US Dollar vs AUD
1.54413
-0.03%
Bitcoin
92,675.66
0.76%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Bivictrix Therapeutics Plc (BVX) Share Price

Bivictrix Therapeutics Plc

Bivictrix Therapeutics Plc (BVX)

LSE
10.00
0.00
(0.00%)
Closed 27 November 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
10.00
Bid
8.50
Offer
9.50
Volume
0.00
0.00 Day's Range 0.00
7.50 52 Week Range 13.00
Market Cap
8.253M
Previous Close
10.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
60,223
Shares Outstanding
82,526,088
Dividend Yield
-
PE Ratio
-3.25
Earnings Per Share (EPS)
-0.03
Revenue
-
Net Profit
-2.55M

About Bivictrix Therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.bivictrix.com
Headquarters
Manchester, Gbr
Founded
-
Bivictrix Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVX. The last closing price for Bivictrix Therapeutics was 10p. Over the last year, Bivictrix Therapeutics shares have traded in a share price range of 7.50p to 13.00p.

Bivictrix Therapeutics currently has 82,526,088 shares in issue. The market capitalisation of Bivictrix Therapeutics is £8.25 million. Bivictrix Therapeutics has a price to earnings ratio (PE ratio) of -3.25.

Ask ADVFN Intelligence (AI)

BVX Latest News

More News

AIM Cancellation - BiVictriX Therapeutics plc

AIM 11 September 2024   NOTICE   11/09/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the Company the following securities have been cancelled from...

11 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 10 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

10 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Last Day of Dealings

BiVictriX Therapeutics PLC 10 September 2024   BiVictriX Therapeutics plc   ("BiVictriX", "BiVictriX Therapeutics" or the "Company")   Last Day of Dealings   Alderley Park, 10 September 2024...

10 September 2024
RNS Regulatory News

Bivictrix Therapeutics optimistic about BVX002 after in vivo testing

Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid ...

10 September 2024
Alliance News

BiVictriX Therapeutics PLC Positive In Vivo Data from BVX002 Programme

BiVictriX Therapeutics PLC 09 September 2024   This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

09 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 02 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

03 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Director Dealing

BiVictriX Therapeutics PLC 02 September 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF...

02 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Result of General Meeting

BiVictriX Therapeutics PLC 29 August 2024   This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

30 August 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

28 August 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

28 August 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10010101000DE
40010101000DE
122.533.33333333337.5107.5602238.75756926DE
26-1-9.0909090909111137.5841528.58685671DE
52-1-9.0909090909111137.5578699.15043992DE
156-14-58.33333333332433.57.54806317.35097106DE
260-12.5-55.555555555622.533.57.56031318.40131837DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
STKStreaksai Plc
0.35p
(59.09%)
8.58M
QEDQuadrise Plc
3.62p
(57.39%)
94.06M
ENWEnwell Energy Plc
23.00p
(46.03%)
160.81k
WEBWebis Holdings Plc
0.125p
(38.89%)
9.14M
INXI-nexus Global Plc
1.50p
(-52.38%)
7.25M
SFRSeverfield Plc
55.60p
(-36.24%)
9.71M
LENDSancus Lending Group Limited
0.30p
(-33.33%)
1.23M
TRYBTribe Technology Plc
2.45p
(-20.97%)
80k
GWMOGreat Western Mining Corporation Plc
0.0175p
(-20.45%)
169.92M
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
NTVONativo Resources Plc
0.0025p
(0.00%)
3.46B
TRPTower Resources Plc
0.0275p
(0.00%)
526.88M
CPXCap-xx Limited
0.145p
(-13.43%)
499.92M
MSMNMosman Oil And Gas Limited
0.038p
(-1.30%)
329.43M

Discussion

View Full Feed
jondoeuk jondoeuk 3 minutes ago
A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr
BGNE
gfp927z gfp927z 3 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
ACXP
dinogreeves dinogreeves 5 minutes ago
Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i
SMCI
bluebird50 bluebird50 6 minutes ago
Guess crows don't like coffee.... delete this post and Crows... 

;-) so we don't witness a murder... a group of crows... Che Che Che 
RDAR
BamaBreeze BamaBreeze 6 minutes ago
Good on you!! Bless us.
BLLB
ducci1 ducci1 6 minutes ago
Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!
VIX
imnot6 imnot6 7 minutes ago
Well, extended duration is their value proposition...
JohnnyHydrogen JohnnyHydrogen 7 minutes ago
AI Czar ?

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

....

"The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."
FCEL
gfp927z gfp927z 8 minutes ago
Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -


Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

gfp927z gfp927z 13 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
Mountainman5 Mountainman5 13 minutes ago
Red Cat & OPT = WinWin!!!!!!!!!!!!!
OPTT
BDEZ BDEZ 14 minutes ago
Thanks georgie..
XRPUSD
$GROO $GROO 15 minutes ago
Never Quit $SANP
Never Quit $SANP $GROO ht
GROO SANP
Oleblue Oleblue 15 minutes ago
In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc
NVDA
JettaR JettaR 16 minutes ago
No one is "rooting" for the stock to go down.  Eyes wide open. Eyes wide open. It's right on front of everyone. 
RGLG
lambchops lambchops 16 minutes ago
Peeps ought to gobble up some NFTM shares for gobble-gobble day!

Eat turkey--not lamb-- on Christmas! Yum-yum.

Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM
NFTM
reaper247 reaper247 18 minutes ago
Always good to hear from ya Drugdoctor.

I suspect we have a few people lurking around.

Hope all GVSIers have as safe and happy Thanksgiving.

GLTA, IMO and FWIW.
GVSI
jondoeuk jondoeuk 19 minutes ago
One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html
FATE
skitahoe skitahoe 20 minutes ago
NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation
AVXL NWBO
jjjjjjjj jjjjjjjj 20 minutes ago
Gummies for dummies -- yummies , LMAO burger flipper
Reply privately from blusher.

Keep doing the 2 steps:
1. SET SELL HIGH our shares.
2. SET BUY HIGHssssssss with last minute and price limit.

MJNA is a good company. Best to us longs.
MJNA
jondoeuk jondoeuk 20 minutes ago
The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html
FATE
gfp927z gfp927z 22 minutes ago
Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

>> given the level of supplementa
jondoeuk jondoeuk 22 minutes ago
They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.
FATE
Plato_ Plato_ 27 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.
GDVM
gimmegimmeminemine gimmegimmeminemine 28 minutes ago
At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
Clear and consice viable proof.

I would be ecstatic if they are ready or already putting out product on a regular basis, be i
KBLB

Your Recent History

LSE
BVX
Bivictrix Therapeutics
BOV
CNFT5L
Agropecuaria Canafistula... PNA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36